CD79b, a core component of the B cell receptor, plays a pivotal role in chronic-active B cell receptor (BCR) signaling and canonical NF-κB signaling pathway of DLBCL survival, especially for the activated B cell-like (ABC) subtype [62]. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.